skip to main | skip to sidebar

The Health, Drug, Prescription, and GMP Supersite

Thoughts and resources about health, drugs and prescriptions, and how they are affected by GMPs (FDA Good Manufacturing Practices) and other regulations.

Wednesday, December 25, 2013

Merry Christmas!


Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog

The Exemptee Institute
The Designated Representative Institute

The Health, Drug, Prescription, and GMP Supersite Gift Store 

Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted by Austin Lee at 4:32 AM

No comments:

Post a Comment

Newer Post Older Post Home
View mobile version
Subscribe to: Post Comments (Atom)

From SkillsPlus International Inc.

Loading...
  • Home
  • SkillsPlus Intl Inc - The Leader in QSR & GMP Training
  • Popular FDA, cGMP, QSR, & GMP Training Courses
  • The Best Exemptee & Designated Representative Training Courses - Online Self-Study
  • CA HMDR Exemptee Certification Class
  • California Exemptee Certification - State Approved
  • The Exemptee Institute
  • The Designated Representative Institute
  • SkillsPlus Intl Inc Blog
  • Home Medical Device Retail - California HMDR Exemptee Training Certification Course
  • Designated Representative Online Training Courses

California Designated Representative Training


Designated Representative Wholesaler Training Course

Designated Representative 3PL Training Course

Designated Representative Reverse Distributor Course

SkillsPlus International Inc. is the ONLY training provider approved by the California State Board of Pharmacy to offer California Designated Representative training programs for wholesalers, 3PL, and reverse distributors. Nearly 10,000 students have taken our state license-related training courses! #2025 #2026 #2027

CA Designated Rep 3PL Course

CA Designated Rep 3PL Course
California Designated Representative 3PL Online Training Course. #2025

The Best Exemptee Training



Sign-up for Exemptee training now!


California HMDR Exemptee license online training certification class for home medical device retailers. Earns a course completion certificate accepted by the California Department of Public Health - Food and Drug Branch. We've added something new, closed captioning. Students can read what the course instructor is teaching. Nearly 10,000 students have taken our state license-related training courses! This feature helps ESL (English as a second language) students, and hard of hearing students. #2025 #2026 #2027

CGMP Online Training Courses

CGMP Online Training Courses
Current Good Manufacturing Practice Training: A New Generation Series - CGMP Online Courses

GMP Trainer Courses

GMP Trainer Courses
GMP Trainer Awareness, Certification, and Master Trainer Courses

Root Cause Analysis - cGMP Training

Root Cause Analysis - cGMP Training
cGMP Training - Online Self-Study Course - Root Cause - Investigation Reports

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments
Subscribe to The Health, Drug, Prescription, and GMP Supersite by Email

Blog List

  • BioPharma Dive - Latest News
    Gilead dips as ‘strong’ earnings outweighed by high expectations for new HIV drug
    3 hours ago
  • BioPharma Dive
    Gilead dips as ‘strong’ earnings outweighed by high expectations for new HIV drug
    3 hours ago
  • CNBC Health Care
    Moderna says FDA refuses to review its application for experimental flu shot
    6 hours ago
  • Medscape Today Headlines
    FDA Clears AI Program for Lung Cancer Screening
    6 hours ago
  • Wellness Blog - NY Times
    Peter Attia’s Ties to Epstein Spark a Backlash From Doctors
    6 hours ago
  • Medtech Insight
    QSIT, Lose It! FDA Inspections Will Now Take a Comprehensive Risk-Based Approach
    6 hours ago
  • Government Executive
    Dem lawmakers propose 4.1% raise for feds in 2027
    7 hours ago
  • eLearning Industry
    Beekeeper Pricing Plans And Costs 2026: Which Plan Is Right For You?
    9 hours ago
  • Pharmaceutical Commerce
    9 hours ago
  • Clarkston Consulting
    2026 Lab Informatics Trends
    10 hours ago
  • FDA What's New: Drugs
    Regulatory Science at CDER
    13 hours ago
  • FierceBiotech
    Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale
    14 hours ago
  • Asbestos and Mesothelioma News
    Parents Secure $850k in Asbestos Day Care Settlement
    14 hours ago
  • FierceBiotech: Medtech
    Merck teams up with British medtech to boost vaginal therapeutics delivery system
    14 hours ago
  • Pharmalot – STAT
    STAT+: Trump administration revives effort to launch pilot initiative reworking drug discount program
    15 hours ago
  • FDA - Press Releases
    FDA Launches Assessment of BHA, a Common Food Chemical Preservative
    15 hours ago
  • All Kaiser Health News
    Obamacare: el impacto de los costos en las inscripciones no se conocerá hasta dentro de varios meses
    15 hours ago
  • FiercePharma
    NIH stops Xarelto arm of stroke trial due to safety, lack of efficacy
    17 hours ago
  • Drug & Device Law
    Stuck on Standing
    18 hours ago
  • Drug Channels
    Copay Accumulators and Maximizers in 2025: Popular, Profitable, and Problematic
    18 hours ago
  • Science-Based Medicine
    The ICEmen Cometh
    21 hours ago
  • JD Supra Law News
    Healthcare Authority Newsletter - February 2026 #1
    1 day ago
  • Marler Blog
    Proud to have another new member of the Marler Clark Team
    2 days ago
  • World Pharma - Breaking News
    Innovative ‘poop pills’ show promising results in clinical trials for multiple types of cancer
    4 days ago
  • Food Poison Journal
    Nine sickened by E. coli from Idaho R Bar H – two Children with Kidney Failure
    5 days ago
  • Pharmafile
    BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer
    5 days ago
  • Quality Matters
    Quality standards and regulatory predictability: A Q&A with USP — Part Two
    6 days ago
  • The Incidental Economist
    Massachusetts Led on Dementia Policy Once. Can it Lead Again?
    6 days ago
  • GEN Biotech News
    New $100M CIRM Initiative Centers Platform Approaches for Rare Genetic Diseases
    1 week ago
  • FDA - Health Fraud
    Umary contains hidden drug ingredients
    1 week ago
  • NPR Blogs: Shots - Health News Blog
    Flu shot recommendation for kids dropped just as the illness rages
    4 weeks ago
  • Ted Eytan, MD
    Brisbane, QLD 🇦🇺
    4 weeks ago
  • Pharmafile - Mfg & Production
    MedPharm announces US FDA inspection of North Carolina manufacturing facility
    5 weeks ago
  • Healthcare Packaging
    Practical Waste Recycling at the Hospital Level: What Are the Odds?
    2 months ago
  • 33 Charts
    The AI coding arms race
    3 months ago
  • The Compliance and Ethics Blog
    Why Compliance Is the Cornerstone of Ethical Medical Billing
    3 months ago
  • Mobihealthnews
    Mendaera gets FDA 510(k) clearance for handheld robotic system
    7 months ago
  • SkillsPlus International Info
    FDA Rushed Out AI Tool
    8 months ago
  • The Health, Drug, Prescription, and GMP Supersite
    Designated Representative Training - California | State-Approved
    8 months ago
  • Modern Healthcare News
    Meet the Administration for a Healthy America, HHS' newest agency
    8 months ago
  • Designated Representative and Exemptee
    Designated Representative Training | Board-Approved Courses | Recommended
    10 months ago
  • Pharma IQ Regulatory-Legal
    AI-Driven Productivity Gains: Transforming Pharma Supply Chain Efficiency
    11 months ago
  • FDA – Policy & Medicine
    FDA Releases Draft Guidance on the Accelerated Approval Process
    11 months ago
  • BioPharma-Reporter RSS
    Inhibikase to pause development of Parkinson’s drug
    1 year ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    1 year ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    1 year ago
  • Biotech Blog
    Making Medicines Affordable: The Role of Generics
    1 year ago
  • BioSpace Regulatory News
    FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm
    1 year ago
  • Healthy Travel Blog
    Hello world!
    1 year ago
  • Quality Digest - FDA Compliance
    Nine Strategies for Effective Internal Audits
    1 year ago
  • Eye on FDA
    FDA Adds New AdComm to Address Genetic Metabolic Diseases
    1 year ago
  • Designated Representative Training Courses
    The Only Board-Approved California Designated Representative Training Programs For ...
    2 years ago
  • HMDR Exemptee Online Training
    California HMDR Exemptee Online Training Certification Course
    2 years ago
  • Medgadget
    Plant-Based Soft Medical Robots
    2 years ago
  • Drug Injury Watch
    Ozempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible, Life-threatening
    2 years ago
  • Golf Foodie
    More women in the U.S. are drinking themselves to death, research finds
    2 years ago
  • PharmaPhorum News
    Patient adherence – the key to restoring trust in pharma
    3 years ago
  • Pharma Manufacturing
    How pharma can overcome inflation
    3 years ago
  • Pharmaceutical Industry | Processing & Engineering: Knowledge, News and Analysis | Pharmaceutical Manufacturing
    How pharma can overcome inflation
    3 years ago
  • CA Designated Rep Training
    Recommended! California Designated Representative Online Training Courses
    6 years ago
  • Clinical Correlations
    Talk to Your Doctor: Direct-to-Consumer Advertising of Prescription Drugs, Part 2
    15 years ago
Show 5 Show All

Blog Archive

  • ►  2025 (1)
    • ►  June (1)
  • ►  2024 (5)
    • ►  August (1)
    • ►  July (1)
    • ►  May (1)
    • ►  March (2)
  • ►  2023 (6)
    • ►  December (1)
    • ►  October (2)
    • ►  July (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2022 (26)
    • ►  November (3)
    • ►  October (1)
    • ►  August (2)
    • ►  July (3)
    • ►  June (4)
    • ►  May (3)
    • ►  April (3)
    • ►  March (1)
    • ►  February (3)
    • ►  January (3)
  • ►  2021 (17)
    • ►  December (2)
    • ►  November (2)
    • ►  October (2)
    • ►  September (2)
    • ►  July (1)
    • ►  April (1)
    • ►  March (1)
    • ►  February (2)
    • ►  January (4)
  • ►  2020 (27)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (4)
    • ►  August (2)
    • ►  July (2)
    • ►  June (2)
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  February (5)
  • ►  2019 (28)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (2)
    • ►  August (3)
    • ►  July (6)
    • ►  June (3)
    • ►  May (2)
    • ►  April (1)
    • ►  February (3)
  • ►  2018 (6)
    • ►  October (1)
    • ►  August (1)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2017 (14)
    • ►  November (1)
    • ►  October (2)
    • ►  August (1)
    • ►  July (1)
    • ►  May (2)
    • ►  April (1)
    • ►  March (1)
    • ►  January (5)
  • ►  2016 (32)
    • ►  December (6)
    • ►  November (4)
    • ►  October (2)
    • ►  September (2)
    • ►  August (2)
    • ►  July (3)
    • ►  June (1)
    • ►  May (3)
    • ►  March (4)
    • ►  February (2)
    • ►  January (3)
  • ►  2015 (68)
    • ►  December (2)
    • ►  November (7)
    • ►  October (10)
    • ►  September (5)
    • ►  August (1)
    • ►  July (6)
    • ►  June (7)
    • ►  May (5)
    • ►  April (3)
    • ►  March (3)
    • ►  February (13)
    • ►  January (6)
  • ►  2014 (105)
    • ►  December (10)
    • ►  November (9)
    • ►  October (1)
    • ►  September (9)
    • ►  August (4)
    • ►  July (6)
    • ►  June (11)
    • ►  May (10)
    • ►  April (10)
    • ►  March (11)
    • ►  February (15)
    • ►  January (9)
  • ▼  2013 (127)
    • ▼  December (7)
      • Merry Christmas!
      • Report: Christmas will kill you | National Monitor
      • We Moved Forward on Many Fronts This Year | FDA Voice
      • Expert Panel Want BP Cuffs Loosened - MedPage Today
      • FDA Drug Quality and Security Act Stakeholder Disc...
      • Procedure Writing Course
      • Nanotech Roundup: Latest National Nanotechnology I...
    • ►  November (14)
    • ►  October (7)
    • ►  September (11)
    • ►  August (7)
    • ►  July (9)
    • ►  June (9)
    • ►  May (6)
    • ►  April (8)
    • ►  March (22)
    • ►  February (9)
    • ►  January (18)
  • ►  2012 (172)
    • ►  December (8)
    • ►  November (20)
    • ►  October (10)
    • ►  September (8)
    • ►  August (4)
    • ►  July (22)
    • ►  June (23)
    • ►  May (17)
    • ►  April (17)
    • ►  March (12)
    • ►  February (13)
    • ►  January (18)
  • ►  2011 (116)
    • ►  December (8)
    • ►  November (15)
    • ►  October (4)
    • ►  September (18)
    • ►  August (9)
    • ►  July (6)
    • ►  June (8)
    • ►  May (9)
    • ►  April (5)
    • ►  March (13)
    • ►  February (10)
    • ►  January (11)
  • ►  2010 (106)
    • ►  December (14)
    • ►  November (8)
    • ►  October (5)
    • ►  September (6)
    • ►  August (10)
    • ►  July (5)
    • ►  June (9)
    • ►  May (11)
    • ►  April (5)
    • ►  March (11)
    • ►  February (10)
    • ►  January (12)
  • ►  2009 (192)
    • ►  December (11)
    • ►  November (11)
    • ►  October (15)
    • ►  September (13)
    • ►  August (10)
    • ►  July (19)
    • ►  June (16)
    • ►  May (16)
    • ►  April (17)
    • ►  March (16)
    • ►  February (19)
    • ►  January (29)
  • ►  2008 (245)
    • ►  December (32)
    • ►  November (39)
    • ►  October (39)
    • ►  September (33)
    • ►  August (52)
    • ►  July (50)

Disclaimer & Privacy Policy

All data and information provided on this site is for informational purposes only. Drughealth.blogspot.com makes no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis. We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.

SkillsPlus International Inc.

SkillsPlus International Inc.
SkillsPlus International Inc. Logo